Survival at 1, 3, and 5 years in diabetic and nondiabetic patients on hemodialysis.
We analyzed survival of 185 adult patients on maintenance hemodialysis (9 h/wk to 12 h/wk) at Emam Khomini Hospital in Ahvaz, Iran. Patient survival at 1, 3, and 5 years was 89.2%, 69.2%, and 46.8%, respectively. There was no significant difference between diabetic and nondiabetic patients in 1-year survival (87.1% versus 89.7%, P = .66). But, 3- and 5-year survival rates of diabetic patients were significantly lower than those of nondiabetic patients (52.2% versus 73.8%, P = .04; zero versus 56.9%, P < .001; respectively). Based on our findings, the survival of diabetic patients undergoing hemodialysis was much worse than survival of nondiabetic patients. Thus, prevention of diabetic nephropathy should be more emphasized; and if end-stage renal disease is present, other renal replacement therapies such as kidney transplantation must be considered as soon as possible.
Beladi Mousavi
Seyed Seifollah
SS
Department of Internal Medicine, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran. beladimusavi@yahoo.com
Hayati
Fatemeh
F
Alemzadeh Ansari
Mohammad Javad
MJ
Valavi
Ehsan
E
Cheraghian
Bahman
B
Shahbazian
Heshmatollah
H
Golzari
Khadijeh
K
Ghorbani
Ali
A
Rashidi
Homira
H
Payami
Peyman
P
Ghaderian
Bahman
B
Eideni
Esmaeel
E
D000328:Adult; D000368:Aged; D003928:Diabetic Nephropathies / Q000401:mortality* / Q000601:surgery / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007492:Iran / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000601:surgery / Q000628:therapy*; D016030:Kidney Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000401:mortality*; D016019:Survival Analysis